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Abstract 
We present a case involving a late diagnosis of chondroblastoma of the temporal skull 
base involving the temporomandibular joint (TMJ). Following an initial misdiagnosis and 
unsuccessful treatment over a period of 5 years, the patient was referred to our 
department for further evaluation and possible surgical intervention for occlusal 
abnormalities, trismus, clicking of the TMJ, and hearing impairment. Based on 
preoperative immunochemical studies showing positive reaction of multinucleated giant 
cells for S-100 protein, the final diagnosis was chondroblastoma. The surgical approach – 
postauricular incision and total parotidectomy, with complete removal of the temporal 
bone, including the TMJ via the extended middle fossa – was successful in preserving 
facial nerves and diminishing clinical manifestations. This study highlights a 
misdiagnosed case in an effort to underline the importance of medical examinations and 
accurate differential diagnosis in cases involving any tumor mass in the temporal bone. 
Introduction 
Chondroblastoma is a rare osseous tumor which accounts for less than 1% of all 
primary bone tumors, and affects the epiphyseal regions of the tubular bones, especially 
the ends of tibia, femur, and humerus [1]. Chondroblastoma localized in the head and  
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neck region is uncommon but characteristically occurs in the temporal bone or the 
temporomandibular joint (TMJ) and results in various symptoms such as occlusal 
abnormalities, trismus, clicking of the TMJ, hearing impairments, dizziness, and otorrhea 
[2]. Malignant changes in chondroblastoma, although rare, have been observed after 
irradiation [3, 4]. In order to avoid the inherent risk of malignant progression, radiation 
therapy should not be considered. However, chondroblastoma in the temporal bone has 
unusual histological features that make diagnosis difficult, and incomplete resection 
carries a high risk of recurrence [5, 6]. Thus, it would seem advisable, provided the 
diagnosis is accurate, to attempt a complete surgical removal for the curative treatment of 
chondroblastoma. 
Following 5 years of unsuccessful treatment, the patient was referred to our 
department presenting with chronic hearing impairments and subsequently progressive 
trismus. A tumor mass was present in the middle cranial fossa, including the TMJ and 
cochlea, in spite of earlier treatment regimens. By reporting this initially misdiagnosed 
case, the present study emphasizes the significance of the principles of a diagnosis. An 
accurate diagnosis was delayed because the original diagnosis relied on imaging analysis 
with neither careful magnetic resonance imaging (MRI)/computed tomography (CT) 
scanning analysis nor histopathologic examination. This less than thorough approach led 
not only to a delay of an accurate diagnosis and to unnecessary treatments, but also to a 
delay of suitable treatments for this rare chondroblastoma with malignant potential. This 
study presents methods which are helpful in diagnosing chondroblastoma, as well as 
suitable surgical procedures for maintaining postoperative functionality. In addition, this 
study highlights some of the problems posed by misdiagnosis. 
Case Report 
A 41-year-old male with TMJ disorder, initially diagnosed with otitis media, presented with a history 
of chronic (lasting more than 1 year) hearing loss on the right side. The patient underwent several 
attempts at antibiotic therapy and treatment for Eustachian tube blockage, but his symptoms were 
unresponsive to both systemic antibiotic agents and tubing therapy. His initial diagnosis of TMJ 
disorder was based on physical assessment of malocclusion and complaints of subsequently developed 
trismus. Therefore, the patient was administered 2 years of splint therapy. After these 2 years, 
endoscopic surgery, followed by several attempts to correct the malocclusion for the TMJ disorder, was 
implemented but resulted in no significant improvement in clinical manifestations. The patient was 
further assessed and a CT scan and pathologic examination showed the presence of a giant cell tumor in 
the temporal bone. No additional treatments were performed. 
The patient harbored the primary disease and consulted us for persistent restriction of the mouth 
opening as well as hearing loss and dizziness, which he had noticed 5 years earlier. He reported 
worsening of dizziness and hearing impairment as time passed. Re-examination of the CT scan revealed 
that the tumor mass had progressively enlarged and had widely destroyed the middle cranial fossa in the 
temporal lobe (fig. 1). MRI displayed the presence of a poorly defined mass, with predominantly low 
signal and relatively high signal intensities, on T1- and T2-weighted sequences, respectively, involving 
the right middle cranial fossa and infratemporal fossa floor. The tumor mass invaded the right temporal 
lobe and destroyed the subzygomatic fossa (fig. 2). Hearing loss in the right ear, trismus, and paralysis 
in V2 had not been reported by the patient before visiting our department. No paralysis was observed in 
V1 and V3, nor in the facial, glossopharyngeal, or hypoglossal nerves. Hard, enlarged lymph nodes were 
palpable in the right cervical region. Re-examination of combined MRI/CT scanning indicated rapid 
enlargement and widespread invasion of the mass into the cranial bone, with enlarged lymph nodes in 
the cervical region, providing evidence for chondrosarcoma or chondroblastoma in the temporal bone 
(data not shown). Preoperative histopathologic studies of the biopsy specimens for S-100 protein (rabbit 
polyclonal antibody; Dako, Denmark) were performed on formalin-fixed, paraffin-embedded tissues, 
using an avidin-biotin-complex method as instructed by the manufacturer. Histopathologic findings  
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showed extensive proliferation of multinucleated giant cells with circular nuclei showing a sheet-like 
structure, formation of a small quantity of acidophilic substrate in the tumor mass, large cystic areas, 
and the presence of hemorrhage and aneurismal bone cysts indicating secondary aneurism-like bone 
cyst formation (fig. 3a, b). The majority of multinucleated giant cells showed reactivity for S-100 protein 
(fig. 3c). At this point, preoperative re-examinations of combined MRI/CT scanning and pathologic 
findings revealed the features of chondroblastoma. 
A generous C-shaped postauricular incision was made through the skin and subcutaneous tissue, 
which was elevated to expose the underlying fascia, periosteum, and muscle. The incision was extended 
down to the cervical region to allow exposure of the sternocleidomastoid (SCM) muscle, the carotid 
artery, and the internal jugular vein. Neck dissection was performed ranging in scope from removal of 
level II and III nodes to possible radical neck dissection, and total parotidectomy was performed while 
leaving facial nerves intact (fig. 4a). A radical mastoidectomy was performed to achieve complete 
exposure of the mastoid and tympanic segments of the facial nerve. The facial nerve was released to 
move easily without traumatic tension. All mucosa from the middle ear and drum was removed. The 
auditory tube was covered with muscles to help prevent infection through the nasopharynx. A 
pericranial flap was elevated to resect the temporalis muscle. A temporal craniotomy was performed. 
Subtotal resection of the temporal bone and skull base dissection with resection of TMJ using a 
zygomatic-extended middle fossa approach was carried out. The temporal lobe dura was resected about 
30 cm
2 together with part of the temporal lobe. The dura was reconstructed using fascia lata and covered 
with the pericranial flap and the temporalis muscle, and reconstruction using the SCM and the platysma 
muscle was performed to prevent infection and dysfunction (fig. 4b). Reconstruction of the facial tissue 
allowed the patient to open his mouth to the extent of 40 mm with no pain (fig. 5). 
This study underlines an attempt to use conventional surgical procedures, with some modifications, 
for the treatment of chondroblastoma in order to prevent postoperative TMJ dysfunction, including 
malocclusion, trismus, and dysphagia, while preserving the masseter, the coronoid process, and the 
anterior part of the temporal muscle. These latter three retain the mandible to the anterior and maintain 
its stability. Reconstruction for facial tissues was carried out by inserting the SCM muscle flap into the 
infratemporal fossa. The SCM flap was then fixed to the resected end of the zygoma inside the mandible. 
This procedure prevented the mandible from transferring to the posterior. The soft tissues around the 
TMJ were removed. 
Four and a half years after surgery, enhanced CT imaging showed no residual tumor. The patient 
had no clinical evidence of tumor recurrence during this period, nor of dizziness, with improvement of 
the occlusal abnormalities and trismus, indicating no postoperative dysfunction. The patient did not 
undergo postoperative irradiation since this is contraindicated with a diagnosis of chondroblastoma. In 
addition, the preservation of facial nerves resulted in recovery without neurological complications. 
Postoperative CT scans confirmed a total excision of the tumor in the temporal region. 
Discussion 
The present study underlines the importance of an accurate diagnosis especially for a 
mass in the temporal bone. Tumors such as chondroblastoma, which may originate as 
benign, may become malignant under inappropriate treatment. In fact, a combined 
radiotherapeutic-surgical approach may provoke neoplastic transformation in the 
residual tumor tissues of chondroblastoma [4, 5, 7]. 
Following an inaccurate diagnosis, the patient in this study had been given various 
therapies for 5 years. The misdiagnosis was attributable to the difficulty of a differential 
diagnosis since the clinical manifestations can be indistinguishable from giant cell tumor, 
chondrosarcoma, aneurismal bone cyst, enchondroma, or chondromyxoid fibroma. 
Immediately before being referred to our department, the patient was misdiagnosed with 
giant cell tumor in the temporal region on the basis of CT scan/MRI plus pathology. 
Accordingly, no treatment was provided. Re-examination of CT/MRI indicated rapid 
enlargement and widely-spread invasion of a mass into the cranial bone, along with  
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enlarged lymph nodes in the cervical region, showing a possibility of chondrosarcoma in 
the temporal bone. However, the widely- and rapidly-enlarged mass was found to have 
infiltrated the temporal lobes, and to have destroyed the middle cranial fossa. Lymph 
nodes in the temporal regions involving the squamosal temporal bone were enlarged. 
These findings provided evidence of malignant chondroblastoma in the temporal bone. 
The subsequent immunohistochemical examination of the lesion showed reactivity of the 
neoplastic protein mass for S-100 protein. The presence of S-100 protein in tumor cells 
differentiates chondroblastoma from giant cell tumor, chondrosarcoma, and aneurismal 
bone cysts, favoring the diagnosis of chondroblastoma [8–10]. The temporal lobes 
revealed extensive proliferation of multinucleated cells. The presence of associated 
aneurismal bone cysts is, while not absolute, a supplemental criteria for the diagnosis of 
chondroblastoma. These findings strongly suggest potentially malignant 
chondroblastoma. 
Treatment of a chondroblastoma in the temporal bone requires total en bloc excision, 
curettage, and irradiation. Postoperative irradiation has been performed with the 
intention to reduce the risk of postoperative recurrence. However, it is not universally 
recommended due to malignant changes in chondroblastoma observed after irradiation. 
Radiation therapy should only be administered in cases of incomplete tumor removal. 
Conclusively, a total en bloc excision should be the first choice as a therapeutic approach 
for chondroblastoma in the temporal bone. In the case presented here, the tumor was 
located in a site that included important neurovascular components, which generally 
makes surgical resection impractical. Thus, accurate, early-stage diagnosis is a vital 
component to successful treatment. For patients with later-stage chondroblastoma, our 
modified surgical procedure is a valuable alternative. 
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Fig. 1. Preoperative CT scans showing invasion of the tumor mass into the right temporal lobe. The 
arrows point out the tumor mass in the right intra-temporal lobe, invading the middle cranial fossa. a 
Sites indicating boney destruction in the middle cranial base. b Inferior sites responsible for the trismus. 
 
 
 
Fig. 2. Preoperative axial T1-/T2-weighted MR image showing invasion of the tumor mass into the 
right temporal lobe. The arrows point out the tumor mass in the right intra-temporal lobe, involving the 
right middle cranial and infratemporal fossae, and the presence of a poorly defined mass with low and 
relatively high signal on T1- (left) and T2- (right) weighted sequences, respectively. 
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Fig. 3. Histopathologic cut confirming the diagnosis of chondroblastoma (HE, a ×100, b ×400). 
Microscopic examination revealed poorly circumscribed tumor with scattered multinucleated giant 
cells and multiple aneurism-like bone cysts with the presence of hemorrhage, representing secondary 
aneurismal bone cyst formation. Immunochemical staining indicates reactivity of the neoplastic cells 
for S-100 protein (c). 
 
  
Case Rep Oncol 2011;4:74–81 
DOI: 10.1159/000324640 
Published online: 
February 14, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
80
 
Fig. 4. Display of the technique for postauricular incision and total parotidectomy leaving facial nerves 
intact. Arrow head shows resected ramus mandible as well as resected dura. Facial nerves are preserved 
(a). Radical mastoidectomy and temporal craniotomy, preventing infection and dysfunction is shown 
(b). The detailed operative techniques are described in the text. 1 = Facial nerve; 2 = resected ramus 
mandible; 3 = SCM muscle reconstructed; 4 = fat covering the tympanic cavity; 5 = temporal bone; 6 = 
pericranial flap. 
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Fig. 5. Reconstruction of facial tissues using a modified surgical procedure. Facial palsy and surgical 
scar are not prominent after reconstructive surgery (upper two photos). Both upper and lower 
malocclusions of teeth are aligned (lower left photo) and chondroblastoma-induced trismus 
significantly improved postoperatively (lower right photo). 
 
References 
1 Dahlin DS, Ivins JC: Benign chondroblastoma. A study of 125 cases. Cancer 1972;30:401–413. 
2 Denko JV, Krauel LH: Benign chondroblastoma of bone: an unusual localization in temporal bone. AMA Arch 
Path 1955;59:710–711. 
3 Hamer SG, Cody DT, Dahlin DC: Benign chondrosarcoma of the temporal bone. Otolaryngol Head Neck Surg 
1979;87:229–236. 
4 Steiner GC: Postradiation sarcoma of bone. Cancer 1965;18:603–612. 
5 Flowers CH, Rodriguez J, Naseem M, Reyes MM, Verano AS: MR of benign chondroblastoma of the temporal 
bone. Am J Neuroradiol 1995;16:414–416. 
6 Politi M, Consolo U, Panziera G, Capelli P, Bonetti F: Chondroblastoma of the temporal bone. J 
Craniomaxillofac Surg 1991;19:319–322. 
7 Horn KL, Hankinson H, Nagel B, Erasmus M: Surgical management of chondroblastoma of the temporal bone. 
Otolaryngol Head Neck Surg 1990;102:264–269. 
8 Bertoni F, Unni KK, Beabou JW, Harner SG, Dahlin DC: Chondroblastoma of the skull and facial bones. Am J 
Clin Pathol 1987;88:1–9. 
9 Hong SM, Park YK, Roj Y: Chondroblastoma of the temporal bone: a clinicopathologic study of five cases. J 
Korean Med Sci 1979;14:559–564. 
10 Watanabe N, Yoshida K, Shigemi H, Kurono Y, Mogi G: Temporal bone chondroblastoma. Otolaryngol Head 
Neck Surg 1999;121:327–330. 